Invention Application
- Patent Title: GENE EXPRESSION MARKERS AND TREATMENT OF MULTIPLE SCLEROSIS
-
Application No.: US18815555Application Date: 2024-08-26
-
Publication No.: US20240410009A1Publication Date: 2024-12-12
- Inventor: Michael Townsend , Alvernia Francesca Setiadi , Tracy Staton
- Applicant: GENENTECH, INC.
- Applicant Address: US CA South San Francisco
- Assignee: GENENTECH, INC.
- Current Assignee: GENENTECH, INC.
- Current Assignee Address: US CA South San Francisco
- Main IPC: C12Q1/6883
- IPC: C12Q1/6883 ; A61K39/00 ; A61K39/395 ; C07K16/24 ; C07K16/28 ; G01N33/564
Abstract:
The present invention concerns markers of multiple sclerosis, their use, and treatment with IL-17 antagonists, including IL-17 antibodies, of subjects with increased levels of such markers.
Information query
